Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease

New England Journal of Medicine

Volumn 334, Issue 18, 1996, Pages 1150-1155

  Omenn, Gilbert S ^a,b   Goodman, Gary E ^a,b,c   Thornquist, Mark D ^a   Balmes, John ^d   Cullen, Mark R ^e   Glass, Andrew ^f   Keogh, James P ^g   Meyskens Jr, Frank L ^h   Valanis, Barbara ^f   Williams Jr , James H ^h   Barnhart, Scott ^a,b   Hammar, Samuel ^b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c SWEDISH MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e YALE UNIVERSITY   (United States)

^f KAISER PERMANENTE   (United States)

^g UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^h UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CAROTENE; RETINOL;

ADULT; AGED; ARTICLE; ASBESTOSIS; CANCER INCIDENCE; CANCER PREVENTION; CANCER RISK; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; HEART DISEASE; HEART INFARCTION PREVENTION; HUMAN; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; SMOKING; TREATMENT OUTCOME;

AGED; ANTIOXIDANTS; ASBESTOS; BETA CAROTENE; CARDIOVASCULAR DISEASES; CAROTENOIDS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MORTALITY; OCCUPATIONAL EXPOSURE; RISK; SMOKING; VITAMIN A;

EID: 9244262406     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199605023341802     Document Type: Article

References (34)

1. Wingo PA, Tong T, Bolden S. Cancer statistics, 1995. CA Cancer J Clin 1995,45:8-30. [Erratum, CA Cancer J Clin 1995;45:127-8.]
2. Cigarette smoking among adults -United States, 1991. MMWR Morb Mortal Wkly Rep 1993;42:230-3.
3. National Center for Health Statistics, Schoenborn CA, Boyd GM. Smoking and other tobacco use: United States, 1987 Vital and Health Statistics. Series 10. No. 169. Washington, D.C.: Government Printing Office, 1989. (DHHS publication no (PHS) 89-1597.)
4. Nicholson WJ, Perkel G, Sehkoff IJ. Occupational exposure to asbestos: population at risk and projected mortality - 1980-2030. Am J Ind Med 1982,3 259-311.
5. Omenn GS, Merchant J. Boatman E, et al. Contribution of environmental fibers to respiratory cancer Environ Health Perspect 1986;70:51-6.
6. Peto R, Doll R, Buckley JD, Sporn MB Can dietary beta-carotene materially reduce human cancer rates? Nature 1981,290:201-8
7. Greenwald P. NCI cancer prevention and control research. Prev Med 1993; 22:642-60
8. Lippman SM, Benner SE. Hong WK. Retinoid chemoprevention studies in upper aerodigestive traut and lung carcinogenesis Cancer Res 1994,54: Suppl.2025s-2028s.
9. Omenn GS, Goodman G, Thornquist M, et al The β-Carotene and Retinol Efficacy Trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos-exposed workers Cancer Res 1994;54: Suppl:2038s-2043s.
10. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers N Engl J Med 1994,330 1029-35
11. Hennekens CH, Buring JE, Manson JE, et al Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996,334:1145-9
12. Buring JE, Hennekens CH. The Women's Health Study: summary of the study design J Myocardial Ischemia 1992;4:27-9.
13. Manson JB, Gaziano JM, Spelsberg A, et al. A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women rationale, design, and methods Ann Epidemiol 1995;5 261-9.
14. Thornquist MD, Omenn GS, Goodman GE, et al. Statistical design and monitoring of the Carotene and Retinol Efficacy Trial (CARET). Controlled Clin Trials 1993;14:308-24.
15. Omenn GS, Goodman GE, Thornquist MD, et al The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations: pilot study with asbestos-exposed workers. Cancer Epidemiol Biomarkers Prev 1993;2.381-7.
16. Goodman GE, Omenn GS. Thornquist MD, Lund B, Metch B, GylysColwell I. The Carotene and Retinol Efficacy Trial (CARET) to prevent lung cancer in high-risk populations, pilot study with cigarette smokers. Cancer Epidemiol Biomarkers Prev 1993;2:389-96
17. Prentice RL A case-cohort design for epidemiologic cohort studies and disease prevention trials. Biometrika 1986,73 1-11.
18. Fleming TR, Harrington DP, O'Brien PC Designs for group sequential tests. Controlled Clin Trials 1984;5:348-61.
19. Steinmetz KA, Potter JD. Vegetables, fruit, and cancer. Cancer Causes Control 1991 ;2:325-57, 427-42.
20. Omenn GS. What accounts for the association of vegetables and fruit with lower incidence of cancers and coronary heart disease? Ann Epidemiol 1995;5.333-5.
21. ISIS-1 (First International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous alenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1 Lancet 1986;2:57-66.
22. ISTS-4 (Fourth International Study of Infarct Survival) Collaborative Group ISIS-4: a randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction Lancet 1995;345. 669-85.
23. Aspirin Myocardial Infarction Study Research Group. A randomized, controlled trial of aspirin in persons recovered from myocardial infarction. JAMA 1980,243:661-9.
24. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17 187 cases of suspected acute myocardial infarction: LSIS-2. Lancet 1988;2 349-60.
25. Yusuf S, Sleight P, Rossi P, et al Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction. Circulation 1983;67:132-41.
26. Omenn GS, Goodman GE, Thornquist M, Brunzell JD. Long-term vitamin A does not produce clinically significant hypertriglyceridemia. results from CARET, the β-Carotene and Retinol Efficacy Trial. Cancer Epidemiol Biomarkers Prcv 1994;3:711-3.
27. Burton GW, Ingold KU. aβ-Carotene an unusual type of lipid antioxidant. Science 1984;224-569-73.
28. Krinsky NI. Actions of carotenoids in biological systems Ann Rev Nutr 1993;13:561-87.
29. Xu MJ, Plezia PM, Alberts DS, et al. Reduction in plasma or skin a-tocopherol concentration with long-term oral administration of β-carotene in humans and mice J Natl Cancer Inst 1992;84 1559-65
30. Goodman GE, Metch BJ, Omenn GS. The effect of long-term β-carotene and vitamin A administration on serum concentrations of α-tocopherol Cancer Epidemiol Biomarkers Prev 1994;3:429-32.
31. Nierenberg DW, Stukel TA, Mott LA, Greenberg ER. Steady-state serum concentration of a tocopherol not altered by supplementation with oral β-carotene J Natl Cancer Inst 1994;86:117-20.
32. McLarty JW. An intervention trial in high-risk asbestos-exposed persons. In: Newell GR, Hong WK, eds. The biology and prevention of aerodigestive tract cancers. Vol. 320 of Advances in experimental medicine and biology New York: Plenum Press, 1992:141-9
33. Block G, Patterson B, Subar A Fruit, vegetables, and cancer prevention: a review of the epidemiology evidence Nutr Cancer 1992,18:1-29.
34. Blot WJ, Li J-Y, Taylor PR, et al. Nutrition intervention trials in Linxian, China. J Natl Cancer Inst 1993;85.1483-92.